Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
World Journal of Urology
Erschienen in: World Journal of Urology 2/2003

01.04.2003 | Topic Paper

Chronic prostatitis: what we know, what we do not know, and what we should do!

verfasst von: B. Lobel, A. Rodriguez

Erschienen in: World Journal of Urology | Ausgabe 2/2003

Einloggen, um Zugang zu erhalten

Abstract

Chronic prostatitis is a major health problem in men. This review details the various types of prostatitis, discusses the possible aetiologies and potential pathogens. In addition, the symptoms and therapies are outlined. Those individuals affected by prostatitis suffer from a markedly reduced quality of life with, in many cases, only a limited benefit from treatment. Many questions remain unanswered, and more research is required in this significant disease.
Literatur
1.
Alexander RB, Brady F, Ponniah S (1997) Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins in men with a history of prostatitis. J Urol 157:S934
2.
Andersen JT (1999) Treatment of prostatodynia. In: Nickel JC (ed) Textbook of prostatitis. ISIS, London
3.
Barbalis GA, Nikiforidis G, Liatsikos EN (1997) Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 159:883–887
4.
Berger RE, Krieger JN, Rothman L et al. (1997) Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol 157:863PubMed
5.
Bergman B (1994) On the relevance of gram-positive bacteria in prostatitis. Infection 22 (Suppl 1):S22PubMed
6.
Brähler E, Würz J, Unger U et al. (1997) The Giessen Prostatitis Symptom Score (GPSS): standardization of the questionnaire and prevalence of symptoms. J Urol 157 (Suppl): 239
7.
Canale D, Scaricabarozzi I, Giorgi P et al. (1993) Use of a novel non-steroidal anti-inflammatory drug, nimesulide, in the treatment of abacterial prostatovesiculitis. Andrologia 25:163–166PubMed
8.
Collins MM, Stafford RS, O'Leary MP et al. (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224PubMed
9.
De la Rossette JJ, Karthaus HF, van Kerrebroeck PE et al. (1992) Research in prostatitis syndrome: the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol 22:222PubMed
10.
Doble A, Walker MM, Harris JRW et al. (1990) Intraprostatic antibody deposition in chronic abacterial prostatitis. Br J Urol 65:598–605PubMed
11.
Egan KJ, Krieger JL (1997) Chronic abacterial prostatitis—a urological chronic pain syndrome? Pain 69:213
12.
Evans DTP. Medical management of chronic non-bacterial prostatitis. In: Nickel JC (ed) Textbook of prostatitis. ISIS, London
13.
Hellstrom W, Shimidt RA, Lue TF et al. (1987) Neuromuscular dysfunction in nonbacterial prostatitis. Urology 30:183PubMed
14.
Hennenfent BR, Feliciano AEJr (1998) Changes in white blood cell counts in men undergoing three-weekly prostatic massage, microbial diagnosis, and anti-microbial therapy for genitourinary complaints. Br J Urol 81:370CrossRefPubMed
15.
Holm M, Meyhoff HH (1996) Chronic prostatitis pain: a new treatment option with finasteride? Scand J Urol Nephro 31:213
16.
Kaplan SA, Te AE, Jacobs BZ (1994) Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder and neck. J Urol 152:2063PubMed
17.
Kaplan SA, Santarosa RP, D'Alisera PM et al. (1997) Pseudodyssinergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 157:2234PubMed
18.
Kirby RS, Lowe D, Bultitude MI et al. (1982) Intraprostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol 121:729
19.
Koff W (1996) Clinical trial comparing lomefloxacin and ofloxacin in the treatment of chronic bacterial prostatitis. Rev Bras Med 53:88–91
20.
Krieger JN, Egan KJ, Ross SO et al. (1996) Chronic pelvic pains represent the most prominent urogenital symptoms of chronic prostatitis. Urology 48:715–722CrossRefPubMed
21.
Krieger JN, Riley DE, Roberts MC et al. (1996) Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 34:3120PubMed
22.
Letran JL, Brawer MK (1999) Prostate specific antigen in prostatitis. In: Nickel JC (ed) Textbook of urology. ISIS, Oxford, pp 241–245
23.
Meares EM (1989) Acute and chronic prostatitis and prostatodynia. In: Fitzpatrick JM, Krane RJ (eds) The prostate. Churchill Livingstone, Edinburgh, pp 62–75
24.
Moon TD (1997) Questionnaire survey of urologists and primary care physicians diagnostic and treatment practices for prostatitis. Urology 50:543CrossRefPubMed
25.
26.
Naber KG, Giamarellou H (1994) Proposed study design in prostatitis. Infection 22 (Suppl 1):S59-S61PubMed
27.
National Institutes of Health (1995) Summary statement. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases workshop on chronic prostatitis. Bethesda, MD
28.
Neal DE, Moon TD (1993) Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 43:460–465
29.
Nickel JC ((1995) Prostatitis. In: Mulholland SG (ed) Antibiotic therapy in urology. Lippincott-Raven, Philadelphia, p 57
30.
Nickel JC, Costerton JW (1993) Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate 23:107PubMed
31.
Nickel JC, Sorensen R (1996) Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. J Urol 155:1950–1955PubMed
32.
Nickel JC, Bruce AW, Reid G (1994) Pathogenesis, diagnosis and treatment of the prostatitis syndromes. In: Krane RJ, Siroky MB (eds) Clinical urology. Lippincott, Philadelphia, p 925
33.
Nickel JC, Nigro M, Voliguette L et al. (1998) Diagnosis and treatment of prostatitis in Canada. Urology 52:797CrossRefPubMed
34.
Osborne DE, George NJ, Rao PN et al. (1981) Prostatodynia: physiological characteristics and rational management with muscle relaxants. Br J Urol 53:621–623PubMed
35.
Persson BE, Ronquist G (1996) Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretions. J Urol 155:958–960PubMed
36.
Pust RA, Ackenheil-Koppe HR, Gilbert P, et al. (1989) Clinical efficacy of ofloxacin (Tarivid) in patients with chronic bacterial prostatitis: preliminary results. J Chemother 1 (Suppl 4):471
37.
Roberts R, Lieber M, Bostwick D, Jacobsen S (1997) A review of clinical and pathological prostatitis syndromes. Urology 49:809–821CrossRefPubMed
38.
Roberts RO, Jacobsen SJ, Rhodes T et al. (1997) A community based study on the prevalence of prostatitis. J Urol 157:242A
39.
Rugendorff EW, Weidner W, Ebeling L (1993) Results of treatment with pollen extracts (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 71:433PubMed
40.
Schaeffer AJ, Darras FS (1990) The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/ or carbenicillin. J Urol 144:690–693PubMed
41.
Shortlife LM, Whener N (1986) The characterization of bacterial and nonbacterial prostatitis by prostatic immunoglobulins. Medicine 65:399PubMed
42.
Stamey T (1980) Urinary tract infections in males. In: Stamey T (ed) Pathogenesis and treatment of urinary tract infections. Williams and Wilkins, Baltimore pp 342–429
43.
44.
Weidner W, Schiefer H-G (1995) Inflamatory disease of the prostate: frequency and pathogenesis. In: Garraway M (ed) Epidemiology of prostate disease. Springer, Heidelberg Berlin, pp 85–93
45.
Weidner W, Schiefer HG, Brähles E (1991) Refractory chronic bacterial prostatitis: a reevaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 146:350–352PubMed
Metadaten
Titel
Chronic prostatitis: what we know, what we do not know, and what we should do!
verfasst von
B. Lobel
A. Rodriguez
Publikationsdatum
01.04.2003
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 2/2003
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-003-0336-1

Weitere Artikel der Ausgabe 2/2003

World Journal of Urology 2/2003 Zur Ausgabe

Topic Paper

Application of real-time polymerase chain reaction technology to detect prostatic bacteria in patients with chronic prostatitis/chronic pelvic pain syndrome

Topic Paper

Recommendations for the evaluation of patients with prostatitis

Topic Paper

Mechanisms of pain in chronic pelvic pain syndrome: influence of prostatic inflammation

Topic Paper

Prostatitis: the role of antibiotic treatment

Topic Paper

The impact of chronic prostatitis/chronic pelvic pain syndrome on patients

Topic Paper

Etiology: where does prostatitis stop and interstitial cystitis begin?

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise